States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

Sino Biopharmaceuticals plans to pay up to $950.9 million to acquire LaNova Medicines, which previously licensed drugs to ...

NHS England agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced a once-monthly PrEP pill ...

The results position Hengrui to seek approval of the Zepbound-like drug in China and Kailera, a well-funded biotech startup, ...